NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001316

Registered date:20/08/2008

Multicenter randomized trial of the prevention of gastric mucosal injury with Rabeprazol in chemotherapeutic cases of pancreatic cancer

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedPancreatic Cancer
Date of first enrollment2007/07/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)A:Rabeprazole(10mg/Day)adiminisitration between 8weeks B:Without administration of any kind of PPI or H2RA

Outcome(s)

Primary OutcomeModified Lanza score
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1 Patients with gastric ulcer or esophagial varices 2 Lanza score, greater or equal 2 3 Direct invasion to gastric or duodenal mucosa 4 Patients who have the symptom of abdominal pain or heartburn 5 Patients who take NSAIDs or steroids 6 Patients who had taken PPI or H2RA within 14 days before start of chemothrapy 7 Patients who had liver chirrosis 8 Patients who ware given gastric resection 9 Performance status, greater or equal 3 10 Patients who had undertaken adverse event caused by PPI 11 Patients who were determined inadequate by doctor

Related Information

Contact

public contact
Name Yoko Yashima
Address 7-3-1,Hongo,Bunkyo-ku,Tokyo Japan
Telephone
E-mail
Affiliation Tokyo University Hospital Department of gastroenterology
scientific contact
Name Hiroyuki Isayama
Address 7-3-1,Hongo,Bunkyo-ku,Tokyo Japan
Telephone
E-mail
Affiliation Tokyo University Hospital Department of gastroenterology